73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Researchers unlock cancer cells' feeding mechanism, central to tumor growth

Researchers unlock cancer cells' feeding mechanism, central to tumor growth

by University of CincinnatiAtsuo Sasaki, Ph.D., associate professor at the UC College of Medicine Credit: Colleen Kelley / UC Creative ServicesAn international team led by researchers from the Un

Researchers unlock cancer cells' feeding mechanism, central to tumor growth

by University of CincinnatiAtsuo Sasaki, Ph.D., associate professor at the UC College of Medicine Credit: Colleen Kelley / UC Creative ServicesAn international team led by researchers from the Un
Understanding how the perception of risks and benefits influences cancer clinical trial withdrawal outcomes

Understanding how the perception of risks and benefits influences cancer clinical trial withdrawal outcomes

byUniversity of Pennsylvania School of NursingCredit: Unsplash/CC0 Public DomainWhile people with cancer have options to participate in cancer clinical trials (CCTs), it can be challenging when

Understanding how the perception of risks and benefits influences cancer clinical trial withdrawal outcomes

byUniversity of Pennsylvania School of NursingCredit: Unsplash/CC0 Public DomainWhile people with cancer have options to participate in cancer clinical trials (CCTs), it can be challenging when
Mitochondrial protein synthesis identified as a potential therapeutic target in lymphoma

Mitochondrial protein synthesis identified as a potential therapeutic target in lymphoma

byUniversity of OxfordSpleen sections from mito-QC mice immunized with SRBC and analyzed on day 12. Scale bar, 50 μm. Representative of three independent experiments. Credit:Nature Immunol

Mitochondrial protein synthesis identified as a potential therapeutic target in lymphoma

byUniversity of OxfordSpleen sections from mito-QC mice immunized with SRBC and analyzed on day 12. Scale bar, 50 μm. Representative of three independent experiments. Credit:Nature Immunol
New drug combinations could improve therapies for breast cancer, other aggressive cancers

New drug combinations could improve therapies for breast cancer, other aggressive cancers

by Angela Yeager,Oregon Health & Science UniversityQuantification of CD8+T cells by multispectral flow cytometry in an ex vivo co-culture assay. Credit:Cell Reports Medicine&nbsp

New drug combinations could improve therapies for breast cancer, other aggressive cancers

by Angela Yeager,Oregon Health & Science UniversityQuantification of CD8+T cells by multispectral flow cytometry in an ex vivo co-culture assay. Credit:Cell Reports Medicine&nbsp
Researchers develop human cell-based model to study small cell lung cancer

Researchers develop human cell-based model to study small cell lung cancer

by Rockefeller University PressLung progenitors (green) form increased numbers of neuroendocrine cells (red) when both the RB gene and the NOTCH signaling pathway are inhibited. Credit: Chen&nbsp

Researchers develop human cell-based model to study small cell lung cancer

by Rockefeller University PressLung progenitors (green) form increased numbers of neuroendocrine cells (red) when both the RB gene and the NOTCH signaling pathway are inhibited. Credit: Chen&nbsp
The Human Tumor Atlas Network: Mapping Cancer's Complexity and Evolution

The Human Tumor Atlas Network: Mapping Cancer's Complexity and Evolution

The Human Tumor Atlas Network (HTAN) stands at the forefront of cancer research, representing a groundbreaking initiative funded by the National Cancer Institute (NCI) as part of the ambitious Cancer Moonshot℠ program. Launched in 2018, HTAN's primary mis

The Human Tumor Atlas Network: Mapping Cancer's Complexity and Evolution

The Human Tumor Atlas Network (HTAN) stands at the forefront of cancer research, representing a groundbreaking initiative funded by the National Cancer Institute (NCI) as part of the ambitious Cancer Moonshot℠ program. Launched in 2018, HTAN's primary mis
​  Vigilant monitoring is needed to manage cardiac risks in patients using antipsychotics, doctors say

​ Vigilant monitoring is needed to manage cardiac risks in patients using antipsychotics, doctors say

by ElsevierCredit: Unsplash/CC0 Public DomainThe use of the antipsychotic drugs quetiapine and haloperidol is associated with an increased risk of ventricular arrhythmias and sudden cardiac death

​ Vigilant monitoring is needed to manage cardiac risks in patients using antipsychotics, doctors say

by ElsevierCredit: Unsplash/CC0 Public DomainThe use of the antipsychotic drugs quetiapine and haloperidol is associated with an increased risk of ventricular arrhythmias and sudden cardiac death
Risks after treatment for cervical neoplasia have declined over time

Risks after treatment for cervical neoplasia have declined over time

by Karolinska InstitutetCredit: Pixabay/CC0 Public DomainThe treatment of serious prodromal cervical cancer, CIN3, can cause problems during later pregnancy amongst women of fertile age. A new re

Risks after treatment for cervical neoplasia have declined over time

by Karolinska InstitutetCredit: Pixabay/CC0 Public DomainThe treatment of serious prodromal cervical cancer, CIN3, can cause problems during later pregnancy amongst women of fertile age. A new re
Clinical study of a blood test shows 83% accuracy for detecting colorectal cancer

Clinical study of a blood test shows 83% accuracy for detecting colorectal cancer

by Fred Hutchinson Cancer CenterCredit: CC0 Public DomainA blood test intended for screening for colorectal cancer in people who are of average risk and not experiencing symptoms correctly detect

Clinical study of a blood test shows 83% accuracy for detecting colorectal cancer

by Fred Hutchinson Cancer CenterCredit: CC0 Public DomainA blood test intended for screening for colorectal cancer in people who are of average risk and not experiencing symptoms correctly detect
Review paper compares two leading pancreatic cancer drugs

Review paper compares two leading pancreatic cancer drugs

by Tyrel Linkhorn,University of ToledoPotential biomarkers in nab-paclitaxel/gemcitabine (a), Folfirinox (b) regimens of drug metabolism and mechanism of action. (c) Macrophages induce gemcitabi

Review paper compares two leading pancreatic cancer drugs

by Tyrel Linkhorn,University of ToledoPotential biomarkers in nab-paclitaxel/gemcitabine (a), Folfirinox (b) regimens of drug metabolism and mechanism of action. (c) Macrophages induce gemcitabi
Boosting the cancer-destroying ability of killer T-cells

Boosting the cancer-destroying ability of killer T-cells

by Julia Short,Cardiff UniversityCredit: CC0 Public DomainMore types of cancer could potentially be destroyed by patients' own immune cells, thanks to new research by Cardiff University.The

Boosting the cancer-destroying ability of killer T-cells

by Julia Short,Cardiff UniversityCredit: CC0 Public DomainMore types of cancer could potentially be destroyed by patients' own immune cells, thanks to new research by Cardiff University.The